4//SEC Filing
Tasker Sybil 4
Accession 0000925421-19-000137
CIK 0001326190other
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 5:49 PM ET
Size
5.8 KB
Accession
0000925421-19-000137
Insider Transaction Report
Form 4
Tasker Sybil
Chief Medical Officer
Transactions
- Award
Stock Options (option to buy)
2019-03-26+38,000→ 38,000 totalExercise: $2.95Exp: 2029-03-26→ Common Stock, par value $0.0001 (38,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent of the shares underlying the option become vested and exercisable on the first anniversary of the Grant Date and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following the one-year anniversary of the Grant Date, in each case, generally subject to the reporting person's continued service through the applicable vesting date.
Documents
Issuer
Altimmune, Inc.
CIK 0001326190
Entity typeother
Related Parties
1- filerCIK 0001705900
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 5:49 PM ET
- Size
- 5.8 KB